# Zanamivir

## Relenza inhalation 5mg/dose (Government)

| TAH Drug Code      | [EREL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EREL)                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of influenza A and B in adults and children >=5 year.                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | (仿單+熱病) Zanamivir is used for treatment of influenza A or B in patients age > or = 7 years or for prophylaxis in patients age > or = 5 years. Treatment: 2 oral inhalations (10 mg) twice daily for 5 days; therapy should begin within 48 hours from onset of signs or symptoms. Prophylaxis: 2 oral inhalations (10 mg) once daily for 10 days or up to 28 days.                                                                                                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity to any of the ingredients of Relenza.                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | Very rarely, allergic-type reactions, including oropharyngeal edema, bronchospasm, dyspnea, rash, urticaria. Central nervous system: Headache (prophylaxis 13% to 24%; treatment 2%) Respiratory: Cough (influenza prophylaxis in pediatric patients, 16% ), Nasal symptom (influenza prophylaxis in pediatric patients, 20% ), Pain in throat (influenza prophylaxis in pediatric patients, 11%), Respiratory depression Other: Fever with chills (influenza prophylaxis, 5% ) |
| Pregnancy          | Compatible – Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                   |

